Ensign Peak Advisors
IOVA icon

Ensign Peak Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Ensign Peak Advisors’s Portfolio IOVA Stock Details IOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-79,442
Closed -$265K – 1708
2025
Q1 		$265K Sell
79,442
-497,823
-86% -$2.57M ﹤0.01% 1658
2024
Q4 		$4.27M Buy
577,265
+502,673
+674% +$4.66M 0.01% 689
2024
Q3 		$700K Hold
74,592
– – ﹤0.01% 1505
2024
Q2 		$598K Buy
74,592
+8,800
+13% +$94.3K ﹤0.01% 1553
2024
Q1 		$975K Buy
+65,792
New +$766K ﹤0.01% 1341
2022
Q4 		– Sell
-251,371
Closed -$2.41M – 1992
2022
Q3 		$2.41M Buy
251,371
+104,250
+71% +$1.2M 0.01% 719
2022
Q2 		$1.62M Buy
147,121
+118,661
+417% +$1.55M ﹤0.01% 893
2022
Q1 		$474K Sell
28,460
-225,020
-89% -$3.48M ﹤0.01% 1571
2021
Q4 		$4.84M Buy
253,480
+59,666
+31% +$1.31M 0.01% 672
2021
Q3 		$4.78M Buy
193,814
+156,909
+425% +$3.7M 0.01% 676
2021
Q2 		$960K Hold
36,905
– – ﹤0.01% 1452
2021
Q1 		$1.17M Sell
36,905
-1,460
-4% -$60.5K ﹤0.01% 1371
2020
Q4 		$1.78M Sell
38,365
-610
-2% -$24.2K ﹤0.01% 1130
2020
Q3 		$1.28M Buy
38,975
+11,556
+42% +$354K ﹤0.01% 1193
2020
Q2 		$753K Hold
27,419
– – ﹤0.01% 1372
2020
Q1 		$821K Buy
27,419
+7,285
+36% +$193K ﹤0.01% 1243
2019
Q4 		$558K Buy
+20,134
New +$458K ﹤0.01% 1493

Other funds holding IOVA

MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ensign Peak Advisors's IOVA Position: Q2 2025 in Review

Ensign Peak Advisors sold out of Iovance Biotherapeutics (IOVA) in Q2 2025, closing a stake of 79,442 shares — an estimated $265K sold.

Ensign Peak Advisors first reported a position in IOVA in Q4 2019 and held it in 17 quarters. The position peaked at $4.84M in Q4 2021. 254 funds tracked by Wall St. Rank hold IOVA as of Q2 2025.

  • Ensign Peak Advisors reported no remaining Iovance Biotherapeutics position as of Q2 2025 after selling out during the quarter.
  • Ensign Peak Advisors sold 79,442 Iovance Biotherapeutics shares in Q2 2025, an estimated $265K.
  • Ensign Peak Advisors first reported a position in Iovance Biotherapeutics in Q4 2019 and held it in 17 quarters.
  • Ensign Peak Advisors's Iovance Biotherapeutics position peaked at $4.84M in Q4 2021.
  • 254 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q2 2025.

Based on Ensign Peak Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.